Johnston SRD, Hegg R, Im SA, Park IH, et al. Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Br J Clin Oncol 2020 Aug 21:JCO2001894. doi: 10.1200/JCO.20.01894.
PMID: 32822287